-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LcBAN19FaV6vx88KxzQhmNjW6/GXHW8YGu/bCU7kh5bReLkB54Sa5zxZSe0QXWpA SKZL/hBmICdCa4ZOcWzx5w== 0001019687-05-003279.txt : 20051129 0001019687-05-003279.hdr.sgml : 20051129 20051129133223 ACCESSION NUMBER: 0001019687-05-003279 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051128 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20051129 DATE AS OF CHANGE: 20051129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIMULATIONS PLUS INC CENTRAL INDEX KEY: 0001023459 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 954595609 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32046 FILM NUMBER: 051231132 BUSINESS ADDRESS: STREET 1: 1220 W. AVENUE J STREET 2: * CITY: LANCASTER STATE: CA ZIP: 93534-2902 BUSINESS PHONE: 661-723-7723 MAIL ADDRESS: STREET 1: 1220 W. AVENUE J CITY: LANCASTER STATE: CA ZIP: 93534-2902 8-K/A 1 simulations_8ka-112905.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 November 28, 2005 ----------------- (Date of the earliest event reported) Simulations Plus, Inc. ---------------------- (Exact name of Registrant as specified in its charter) California 001-32046 95-4595609 ---------- --------- ---------- (State or other jurisdiction (Commission File Number) (I.R.S. Employer of incorporation) Identification No.) 1220 West Avenue J, Lancaster, California 93534 ----------------------------------------------- (Address of principal executive offices) (Zip Code) (661) 723-7723 -------------- Registrant's telephone number, including area code 1 ITEM 8.01. OTHER EVENTS On November 28, 2005, Simulations Plus, Inc., a California corporation (the "Company") issued a press release announcing that it has terminated its former investor relations agreement with Cameron and Associates and will move this function in-house. ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (a) Exhibits 99.1 Press release dated November 28, 2005 2 Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SIMULATIONS PLUS, INC. Dated: November 29, 2005 By: /s/ Momoko Beran ---------------------------- Momoko A. Beran Chief Financial Officer 3 EXHIBITS INDEX -------------- Exhibit Number Description -------------- ----------- 99.1 Press release, dated November 28, 2005 4 EX-99.1 2 simulations_8ka-ex9901.txt EXHIBIT 99.1 SIMULATIONS PLUS Integrating Science and Software For Further Information: SIMULATIONS PLUS, INC. 1220 W. Avenue J Lancaster, CA 93534-2902 661.723.7723 www.simulations-plus.com CONTACT: Investor Relations - ------------------ Ms. Renee Bouche Simulations Plus, Inc. 661.723.7723 info@simulations-plus.com For Immediate Release: November 28, 2005 SIMULATIONS PLUS ANNOUNCES CHANGE IN INVESTOR RELATIONS FUNCTION TO BE MOVED IN-HOUSE FOR GREATER OPERATING EFFICIENCY LANCASTER, CA, NOVEMBER 28, 2005 --Simulations Plus, Inc. (AMEX: SLP), the leading provider of ADMET absorption simulation and structure-to-property prediction software for pharmaceutical discovery and development, announced today that it has terminated its former investor relations agreement with Cameron and Associates and will move this function in-house. Walt Woltosz, chairman and chief executive officer of Simulations Plus, said, "As the company has grown and we have learned more about how to handle investor relations issues, we have decided to do as many other companies have done and bring this function in-house. We believe that this will provide greater shareholder value through both a significant cost savings, as well as allowing a greater number of person-hours to be applied to this function to provide a more active IR program." ABOUT SIMULATIONS PLUS, INC. Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company has two other businesses, Words+, Inc. and FutureLab(TM), which are based on its proprietary software technologies. Simulations Plus, Inc., is headquartered in Southern California. For more information, visit our Web site at www.simulations-plus.com. ### 5 -----END PRIVACY-ENHANCED MESSAGE-----